Schizophrenia has long been recognized to be accompanied by greater physical morbidity and elevated mortality (Meyer and Nasrallah, 2009). Yet, it is only relatively recently that investigators have begun to fully explore the possibility that the schizophrenia syndrome affects not only the brain but the rest of the body as well. This multi-systemic view of the disorder was initially proposed in a review by Kirkpatrick and Galderisi (2008) who posed the question of whether schizophrenia was a disease of accelerated aging. By focusing the field on the notion that aging of both body and brain might be more rapid in people with schizophrenia compared to those without a serious mental illness, their review consolidated previous work and suggested studying the syndrome through a new prism.This Special Issue begins with an updated review from Kirkpatrick and Kennedy (2018). The authors once again consider the complex relationship between disease and aging in schizophrenia, and whether it might qualify as a segmental progeroid syndrome, characterized by some but not all aspects of accelerated aging. In briefly reviewing progress in testing some of the hypotheses of their original article (Kirkpatrick and Galderisi, 2008), the authors note some areas in which evidence is consistently supportive of accelerated aging (e.g., glucose tolerance and insulin resistance, prolactin, inflammation, and oxidative stress) and others where the evidence is more mixed (e.g., cognition and telomere length). They highlight the need for more longitudinal studies, and emphasize the importance of accounting for potential confounds such as antipsychotic use, ethnicity, gender, socioeconomic status, lifestyle factors (e.g., sedentary lifestyle, smoking, diet), and body mass index in studies of accelerated aging in schizophrenia.Furthermore, within the schizophrenia syndrome, subgroups may exist that are determined by clinical features, genetic or environmental risk factors, level of inflammation, or other factors. These subgroups may also differ in whether or not, or in what systems, accelerated aging occurs. The authors then considered seven inter-related mechanistic pathways thought to be involved in aging: epigenetic changes/DNA methylation, inflammation, proteostasis, including the mTOR signaling factor, adult stem cell function, metabolic changes, adaptation to stress, and macromolecu-